Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Octyl Triazone Sales Of 400 Mil. Sunscreen Units Abroad Cited By FDA

This article was originally published in The Tan Sheet

Executive Summary

Based on bulk material sales, nearly 400 mil. sunscreen dosage units containing octyl triazone have been sold in 35 countries, FDA notes in an evaluation of BASF's time and extent application for including the ingredient in the OTC sunscreen monograph

You may also be interested in...



Octyl Triazone 3% Alone In Sunscreens Offers SPF 9 – BASF

Octyl triazone is an effective UVB filter at a concentration of 3% that, when used alone, provides an SPF of nine, according to efficacy data submitted to FDA by the law firm Morgan Lewis on behalf of ingredient supplier BASF

Octyl Triazone 3% Alone In Sunscreens Offers SPF 9 – BASF

Octyl triazone is an effective UVB filter at a concentration of 3% that, when used alone, provides an SPF of nine, according to efficacy data submitted to FDA by the law firm Morgan Lewis on behalf of ingredient supplier BASF

Octyl Triazone 3% Alone In Sunscreens Offers SPF 9 – BASF

Octyl triazone is an effective UVB filter at a concentration of 3% that, when used alone, provides an SPF of nine, according to efficacy data submitted to FDA by the law firm Morgan Lewis on behalf of ingredient supplier BASF

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095747

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel